S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabine

Pegaspargase combined with gemcitabine have greatly improved the outcomes of advanced extranodal NK/T cell lymphoma (ENKL). However, patients frequently undergo recurrent disease due to chemoresistance, and few predictive parameters are available. The present study explored potential biomarkers to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhiyuan, Li, Zhaoming, Sun, Zhenchang, Zhang, Xudong, Lu, Lisha, Wang, Yingjun, Zhang, Mingzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810364/
https://www.ncbi.nlm.nih.gov/pubmed/27021626
http://dx.doi.org/10.1038/srep23695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810364/
https://www.ncbi.nlm.nih.gov/pubmed/27021626
http://dx.doi.org/10.1038/srep23695

Ejemplares similares